✦ LIBER ✦

CEBPA point mutations in hematological malignancies

✍ Scribed by Leroy, H; Roumier, C; Huyghe, P; Biggio, V; Fenaux, P; Preudhomme, C

Book ID: 110056137
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 145 KB
Volume: 19
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pooled analysis of p53 mutations in hema

Pooled analysis of p53 mutations in hematological malignancies

✍ Miron Prokocimer; Ron Unger; Hedy S. Rennert; Varda Rotter; Gad Rennert 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 3 views

A computerized database is described that contains information about 507 mutations in the p53 gene of hematologic tumors and corresponding cell lines. Analysis of these mutations indicated the following findings: First, mutational spectrum analysis in these tumors was found to be similar to the patt

Mutations of the WT1 gene in childhood n

Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies

✍ Kiyoshi Miyagawa; Yasuhide Hayashi; Toshikatsu Fukuda; Kinuko Mitani; Hisamaru H 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

The Wilms' tumor gene WT1, whose loss of function accounts for the genesis of about 10% of Wilms' tumors, is expressed in hematopoietic stem cells and leukemia. By analogy with the relationship between the kidney stem cell and Wilms' tumor, it is probable that WT1 is mutated in leukemia. WT1 mutatio

α-interferon in hematological malignanci

α-interferon in hematological malignancies

✍ Frank J. Giles; Howard Ozer 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Recent studies have generated data demonstrating significant clinical activity of a-interferon therapy in each of six hematological malignancies, chronic myeloid leukaemia, essential thrombocythemia, polycythemia rubra vera, non-Hodgkin's lymphomas, multiple myelomatosis and hairy cell leukaemia.

Centrosome aberrations in hematological

Centrosome aberrations in hematological malignancies

✍ Alwin Krämer; Kai Neben; Anthony D. Ho 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Tissue factor in hematological malignanc

Tissue factor in hematological malignancies

✍ Ribatti, D 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 60 KB

Molecular genetic biomarkers in hematolo

Molecular genetic biomarkers in hematological malignancies

✍ Adam Bagg; Jeffrey Cossman 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 679 KB

Most hematopoietic malignancies are widely disseminated even in their "early" stages and often do not have a well-defined localized phase. This makes them less amenable to conventional early screening methods such as imaging and observation. Furthermore, the staging systems for lymphomas are not par